Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
about
The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation.Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting.Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation.Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants.
P2860
Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Non-Vitamin K Antagonist Oral ...... Randomized Controlled Trials.
@en
type
label
Non-Vitamin K Antagonist Oral ...... Randomized Controlled Trials.
@en
prefLabel
Non-Vitamin K Antagonist Oral ...... Randomized Controlled Trials.
@en
P2093
P1433
P1476
Non-Vitamin K Antagonist Oral ...... Randomized Controlled Trials.
@en
P2093
Andrea Natale
Conor D Barrett
Jacqueline S Danik
Robert K Altman
Saurav Chatterjee
Shashi Kumar
Stephan B Danik
P304
P356
10.1097/CRD.0000000000000088
P577
2015-08-11T00:00:00Z